Chien et al., “Diagnosis of hepatitis C virus (HCV) infection using an immunodominant chimeric polyprotein to capture circulating antibodies: Reevaluation of the role of HCV in liver disease,” Proc. Natl. Acad. Sci. USA, 1992, 89, 10011-10015. |
Choo et al., “Isolation of a cDNA Clone Derived from a Blood-Borne Non-A, Non-B Viral Hepatistis Genome,”Science, 244, 359-362. |
Cousens et al., “High level expression of proinsulin in the yeast, Saccharomyces cerevisiae,” Gene, 1987, 61, 265-275. |
Ebeling et al., “Second-generation RIB A to confirm diagnosis of HCV infection,” Lancet, 1991, 337, 912-913. |
Kotwal et al., “Detection of acute hepatitis C virus infection by ELISA using a synthetic peptide comprising a structural epitope,” Proc. Natl. Acad. Sci. USA, 1992, 89, 4486-4489. |
Kuo et al., “An Assay for Circulating Antibodies to a Major Etiologic Virus of Human Non-A, Non-B Hepatitis,”Science, 1989, 244, 362-364. |
Sallberg et al., “Immunodominant Regions within the Hepatitis C Virus Core and Putative Matrix Proteins,”J. Clin. Microbiol., 1992, 30(8), 1989-1994. |
Cohard, M. et al., “Hepatitis C virus-specific CTL respones in PBMC from chimpanzees with chronic hepatitis C: determination of CTL and CTL precursor frequencies using a recombinant canarypox virus (ALVAC)”, J. Immunol. Methods, 1998, 214(1-2), 121-129. |
Ide, Y. et al., “Hepatitis C virus NS5A protein is phosphorylated in vitro by a stabley bound protein kinase from HeLa cells and by cAMP-dependent protein kinase A-alpha catalytis subunit”, Gene, 1997, 201(1-2), 151-158. |
Patent Abstracts of Japan, JP 06-074956 A, published Mar. 18, 1994, 1 page. |